| Product Code: ETC9944964 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Fungal Infections Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Fungal Infections Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Fungal Infections Market - Industry Life Cycle |
3.4 United Kingdom (UK) Fungal Infections Market - Porter's Five Forces |
3.5 United Kingdom (UK) Fungal Infections Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 United Kingdom (UK) Fungal Infections Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 United Kingdom (UK) Fungal Infections Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 United Kingdom (UK) Fungal Infections Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 United Kingdom (UK) Fungal Infections Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 United Kingdom (UK) Fungal Infections Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 United Kingdom (UK) Fungal Infections Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Fungal Infections Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of fungal infections in the UK due to factors such as aging population, weakened immune systems, and rising incidences of chronic diseases. |
4.2.2 Growing awareness about the importance of early detection and treatment of fungal infections, leading to higher diagnosis rates. |
4.2.3 Technological advancements in diagnostic tools and treatment options, improving patient outcomes and driving market growth. |
4.3 Market Restraints |
4.3.1 Limited availability of effective antifungal medications in the UK market. |
4.3.2 High costs associated with treatment and management of fungal infections, potentially limiting access to care. |
4.3.3 Lack of standardized guidelines for the diagnosis and management of fungal infections, leading to variability in treatment approaches. |
5 United Kingdom (UK) Fungal Infections Market Trends |
6 United Kingdom (UK) Fungal Infections Market, By Types |
6.1 United Kingdom (UK) Fungal Infections Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Aspergillosis, 2021- 2031F |
6.1.4 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Blastomycosis, 2021- 2031F |
6.1.5 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Candidiasis, 2021- 2031F |
6.1.6 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Candida auris, 2021- 2031F |
6.1.7 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Coccidioidomycosis, 2021- 2031F |
6.1.8 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Cryptococcus gattii infection, 2021- 2031F |
6.2 United Kingdom (UK) Fungal Infections Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2.3 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Corticosteroid-Sparing Agents, 2021- 2031F |
6.2.4 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Immunosuppressive, 2021- 2031F |
6.2.5 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Immunomodulator, 2021- 2031F |
6.2.6 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Antifungals, 2021- 2031F |
6.2.7 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Fungal Infections Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Antifungal, 2021- 2031F |
6.3.3 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Fungal Infections Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Creams, 2021- 2031F |
6.4.3 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Gels, 2021- 2031F |
6.4.4 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Ointment, 2021- 2031F |
6.4.5 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Solution, 2021- 2031F |
6.4.6 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Lotions, 2021- 2031F |
6.4.7 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Fungal Infections Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Topical, 2021- 2031F |
6.5.5 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Vaginal, 2021- 2031F |
6.5.6 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Kingdom (UK) Fungal Infections Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.5 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.7 United Kingdom (UK) Fungal Infections Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 United Kingdom (UK) Fungal Infections Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Fungal Infections Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Fungal Infections Market Export to Major Countries |
7.2 United Kingdom (UK) Fungal Infections Market Imports from Major Countries |
8 United Kingdom (UK) Fungal Infections Market Key Performance Indicators |
8.1 Rate of fungal infection cases diagnosed annually in the UK. |
8.2 Adoption rate of advanced diagnostic technologies for fungal infections. |
8.3 Number of clinical trials and research studies focused on developing new antifungal treatments. |
8.4 Percentage of healthcare professionals trained in the latest guidelines for managing fungal infections. |
9 United Kingdom (UK) Fungal Infections Market - Opportunity Assessment |
9.1 United Kingdom (UK) Fungal Infections Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 United Kingdom (UK) Fungal Infections Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 United Kingdom (UK) Fungal Infections Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 United Kingdom (UK) Fungal Infections Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 United Kingdom (UK) Fungal Infections Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 United Kingdom (UK) Fungal Infections Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 United Kingdom (UK) Fungal Infections Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Fungal Infections Market - Competitive Landscape |
10.1 United Kingdom (UK) Fungal Infections Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Fungal Infections Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here